16-4797972-C-G
Variant summary
Our verdict is Likely pathogenic. The variant received 6 ACMG points: 6P and 0B. PM2PP3_Strong
The NM_024589.3(ROGDI):c.661G>C(p.Gly221Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000137 in 1,607,560 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Uncertain significance in ClinVar.
Frequency
Consequence
NM_024589.3 missense
Scores
Clinical Significance
Conservation
Publications
- amelocerebrohypohidrotic syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, ClinGen, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 6 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ROGDI | NM_024589.3 | c.661G>C | p.Gly221Arg | missense_variant | Exon 9 of 11 | ENST00000322048.12 | NP_078865.1 | |
| ROGDI | XM_006720947.5 | c.661G>C | p.Gly221Arg | missense_variant | Exon 9 of 11 | XP_006721010.1 | ||
| ROGDI | XM_047434636.1 | c.391G>C | p.Gly131Arg | missense_variant | Exon 7 of 9 | XP_047290592.1 | ||
| ROGDI | NR_046480.2 | n.668G>C | non_coding_transcript_exon_variant | Exon 8 of 10 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ROGDI | ENST00000322048.12 | c.661G>C | p.Gly221Arg | missense_variant | Exon 9 of 11 | 1 | NM_024589.3 | ENSP00000322832.6 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152208Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.00000809 AC: 2AN: 247070 AF XY: 0.0000149 show subpopulations
GnomAD4 exome AF: 0.0000144 AC: 21AN: 1455352Hom.: 0 Cov.: 36 AF XY: 0.0000166 AC XY: 12AN XY: 722962 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152208Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74354 show subpopulations
ClinVar
Submissions by phenotype
Amelocerebrohypohidrotic syndrome Uncertain:1
This sequence change replaces glycine with arginine at codon 221 of the ROGDI protein (p.Gly221Arg). The glycine residue is highly conserved and there is a moderate physicochemical difference between glycine and arginine. This variant is present in population databases (rs757872277, ExAC 0.009%). This variant has not been reported in the literature in individuals affected with ROGDI-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at